Previous Article | Next Article 
Infection and Immunity, November 1998, p. 5314-5321, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
1,25-Dihydroxyvitamin D3 Induces Nitric
Oxide Synthase and Suppresses Growth of Mycobacterium
tuberculosis in a Human Macrophage-Like Cell Line
Kirk A.
Rockett,1,*
Roger
Brookes,2
Irina
Udalova,1
Vincent
Vidal,1
Adrian V. S.
Hill,2 and
Dominic
Kwiatkowski1
Molecular Infectious Disease
Group1 and the
Molecular Immunology
Group,2 Institute of Molecular Medicine,
John Radcliffe Hospital, Oxford, United Kingdom
Received 4 February 1998/Returned for modification 22 April
1998/Accepted 29 July 1998
 |
ABSTRACT |
Inducible synthesis of nitric oxide (NO) by macrophages is an
important mechanism of the host defense against intracellular infection
in mice, but the evidence for significant levels of inducible NO
production by human macrophages is controversial. Here we report that
the human promyelocytic cell line HL-60, when differentiated to a
macrophage-like phenotype, acquires the ability to produce substantial
amounts of NO on stimulation with LPS or 1,25-dihydroxyvitamin
D3 (1,25-D3) in the absence of activating factors such as gamma interferon. Expression of the inducible nitric
oxide synthase (NOS2) was confirmed by sequencing of the reverse
transcription-PCR product from stimulated HL-60 cells. Kinetic studies
after lipopolysaccharide stimulation show that NOS2 mRNA levels rise
within 3 to 6 h, that conversion of [14C]arginine to
[14C]citrulline is maximal at 5 to 6 days, and that
levels of reactive nitrogen intermediates stabilize at around 20 µM
at 7 to 8 days. We find that 1,25-D3 acts to suppress the
growth of Mycobacterium tuberculosis in these cells and
that this effect is inhibited by
NG-monomethyl-L-arginine,
suggesting that vitamin D-induced NO production may play a role in the
host defense against human tuberculosis.
 |
INTRODUCTION |
A major area of immunological
controversy is whether human macrophages possess the capacity to
produce significant amounts of nitric oxide (NO) in response to
infection (15). For mice there is abundant evidence that
microbial and parasitic pathogens stimulate the high-output pathway of
inducible NO synthesis in macrophages and that this constitutes an
important arm of host defense (reviewed in references 9,
16, and 27). In contrast, human monocytes
and macrophages generally fail to produce NO when stimulated in vitro
with agents that induce a strong NO response in murine macrophages,
such as lipopolysaccharide (LPS) plus gamma interferon. This has led
several investigators to assert that human macrophages cannot generate
antimicrobial concentrations of NO (15). However, a number
of recent studies have documented NO release by human macrophages in
vitro following unconventional stimuli such as infection with human
immunodeficiency virus type 1 (5) or cross-linking of the
surface receptor CD69 (14) or CD23 (41). Thus,
there is an emerging view that human macrophages are capable of
inducible NO synthesis but that this response may depend on factors
such as the precise state of macrophage differentiation, complex
stimuli, or tissue location.
An important question arising from these observations is the role of NO
in the host defense against tuberculosis. For mice, studies conducted
both in vivo and in vitro provide compelling evidence that macrophages
can kill various mycobacterial species, including Mycobacterium
tuberculosis, through an NO-dependent pathway (7, 23, 24,
33). The situation in humans is less clear. It has been observed
that pulmonary alveolar macrophages from patients with tuberculosis
express inducible nitric oxide synthase (NOS2) (27), but
thus far there has been no evidence that human macrophages utilize NO
to kill M. tuberculosis, although killing of other
mycobacterial species has been described (28).
One way of addressing this problem is to search for NO-producing human
macrophage-like cell lines that might ultimately provide clues to the
regulation and function of inducible NO synthesis in vivo. The human
promyelocytic cell line HL-60 has been extensively studied for its
ability to differentiate into a variety of myelomonocytic phenotypes (11). Here we report on a line of HL-60 cells
that, after a period of continuous culture at high ambient
CO2 concentrations, adopted characteristic macrophage-like
properties, including adherence, CD14 expression, the ability to
phagocytose latex particles, and lack of nitroblue tetrazolium (NBT)
reduction. LPS alone is sufficient to stimulate high levels of nitric
oxide production by these cells, and several lines of evidence
demonstrate that this is due to induction of the NOS2 gene.
Unexpectedly, we find that 1,25-dihydroxyvitamin D3
(1,25-D3) is also a potent stimulus for NO production in
this cell type, a result which is intriguing in view of the role played by vitamin D in the host defense against tuberculosis (35). Furthermore, we observe that 1,25-D3 acts to suppress the
growth of M. tuberculosis in this macrophage-like HL-60
line, at least partly through an NO-dependent mechanism.
 |
MATERIALS AND METHODS |
Cell culture.
The human myeloblastic cell line HL-60 (ATCC
CCL-240) was grown in Dulbecco modified Eagle medium (chosen for its
low [<1 µM] nitrate content) supplemented with 10%
heat-inactivated newborn calf serum, 2 mM L-glutamine, 10 IU of benzoylpenicillin per ml, 100 µg of streptomycin per ml, an
extra 1 g of NaHCO3 per liter, and 1 g of
D-glucose per liter. All materials were purchased from Sigma (Poole, United Kingdom). Cells were incubated at 37°C in a
7.5% CO2 atmosphere. Other conditions are described in
Results.
Characterization.
Five million cells in 3 ml of medium were
plated in six-well flat-bottomed plates, with or without 100 ng of LPS
from Escherichia coli 0128:B12 (Sigma) per ml, for 24 h, after which the cells were resuspended and 100 µl of cell
suspension per well was plated in 96-well flat-bottomed plates.
(i) Phagocytosis.
Five microliters of a 1:10 dilution of
fluorescinated latex beads (5-µm diameter; Sigma) per well was
added and left for 2 h. Cells were inspected by UV-light
microscopy.
(ii) NBT reduction.
Five microliters of a 1-mg/ml
solution of NBT (Sigma) in phosphate-buffered saline (PBS) per well was
added and left for 2 h, after which the cells were inspected by
microscopy. Cells reducing NBT normally contained blue-black granules.
(iii) Surface markers.
HL-60 cells (106 cells in
PBS) were stained with either anti-human CD14 (Sigma), anti-human CD23
(Sigma), or an isotype control (Sigma) by an indirect
immunofluorescence technique with a secondary antibody (goat anti-mouse
immunoglobulin-fluorescein isothiocyanate conjugate from Sigma) as per
the manufacturer's instructions. Both FACScan analysis (Becton
Dickinson, Oxford, United Kingdom) and microscopy were used to
determine the number of positively stained cells.
(iv) NADPH-diaphorase.
A method described previously
(18) was used. Briefly, culture medium was removed from the
wells, and the cells were fixed in situ with 4% paraformaldehyde in
PBS. The cells were washed and stained with NADPH-NBT buffer at 37°C
for 45 min, after which they were washed and left in PBS for
microscopy.
Stimulation assays.
Fifty microliters of cells in culture
medium was added to 50 µl of medium containing stimulants in 96-well,
flat-bottomed plates. After incubation at 37°C in 7.5%
CO2 for various periods of time (specified in Results), the
plate was wrapped in cling film and stored at
20°C until assayed
for nitric oxide production. The stimulants used were phorbol myristic
acetate (PMA), LPS from E. coli 0128:B12,
1,25-D3, ergocalciferol, and cholecalciferol, all purchased
from Sigma. The vitamin D analogues were dissolved in dimethyl
sulfoxide (DMSO) and stored at
70°C.
NG-Methyl-L-arginine
(L-NMMA) and
NG-methyl-D-arginine
(D-NMMA) were synthesized as described previously (30).
Time course experiments.
HL-60 cells (3 × 106) were plated in 24-well flat-bottomed plates in 2 ml of
medium containing 100 ng of E. coli LPS per ml. Each day the
contents of one well were harvested into a 2-ml centrifuge tube (BDH),
while 10% of the medium was replaced with fresh medium (containing 100 ng of E. coli LPS per ml) in the remaining wells. Harvested
cells were briefly centrifuged at 10,000 × g. The
supernatant was stored at
20°C until assayed for NO, and the cells
were dissolved in Tri-Reagent (Sigma) prior to RNA extraction for
Northern blotting or reverse transcription-PCR (RT-PCR). Parallel
cultures were set up in duplicate, using 1.5 × 105
cells in 100 µl of medium containing 100 ng of E. coli LPS
per ml, in 96-well flat-bottomed plates for assay of NOS activity by
arginine-to-citrulline conversion. As described above, 10% of the
culture medium was replaced with fresh medium plus 100 ng of E. coli LPS per ml every 24 h. On the day before harvesting of
cells, 250 nCi of L-[U-14C]arginine with a
specific activity of 317 mCi/mmol (Amersham International PLC,
Amersham, United Kingdom) was added to the well. The rate of
arginine-to-citrulline conversion was assayed by high-pressure liquid
chromatography (HPLC) as described below.
Measurement of reactive nitrogen intermediates (RNI) (nitrite
plus nitrate).
Stock solutions of sodium nitrite and sodium
nitrate (Sigma) at 100 mM in water were stored at 4°C stock solutions
of nitrate reductase (Boehringer Mannheim, Lewes, United Kingdom) at
2.5 U/ml and a mixture of NADPH (Sigma) at 1.67 mg/ml plus flavin adenine dinucleotide (Boehringer Mannheim) at 0.05 mg/ml in water were
stored at
20°C. Prior to use, 1 volume of nitrate reductase was
mixed with 3 volumes of NADPH-flavin adenine dinucleotide (enzyme
mixture). Griess reagent was prepared as previously described (34). The assay was performed in nonsterile 96-well
flat-bottomed plates. The samples were divided between two plates (50 µl added to each), one for measuring nitrite and the other for
measuring nitrate, each containing appropriate standards. Water (20 µl per well) was added to the nitrite plate, and enzyme mixture (20 µl per well) was added to the nitrate plate. All plates were
incubated for 30 min at room temperature. Griess reagent (100 µl per
well) was added and left for 5 min at room temperature, and then the optical densities (ODs) in all plates were read at 620 nm (reference) and 540 nm (test). Nitrite concentrations were calculated directly from
the nitrite standard curve. To determine nitrate concentration, ODnitrite was subtracted from ODnitrate before
comparison with the nitrate standard curve. Medium alone was used to
calculate the assay background level, and this was subtracted from all
data.
Measurement of arginine-to-citrulline conversion.
The
measurement of arginine-to-citrulline conversion, which indicates the
rate of NO synthesis, was performed as previously described
(8). Briefly, 100 µl of a 10% trichloroacetic acid solution (Sigma) per microtiter well of cultured cells was added, the
mixture was centrifuged at 10,000 × g for 5 min, and
the supernatant (175 µl) was transferred to an HPLC autosampler vial
(Sigma). Ten microliters of a 1:100 dilution of
D-[3H]glucosamine (specific activity, 20 to
40 Ci/mmol; Amersham) per vial was added. Standards of
14C-labelled arginine and ornithine (both from Amersham)
and citrulline (NEN-DuPont, Hounslow, United Kingdom) were used to
determine elution times. Samples (150 µl of each) were analyzed on a
250- by 4-mm SCX300 cation-exchange column (Sigma), using a Beckman (High Wycombe, United Kingdom) HPLC system consisting of a 507e Autosampler, 128 dual pumps, 171 continuous-flow liquid-scintillation detector, and System Gold software version 6.4. Running conditions were
as follows: buffer A, 0.01 M sodium citrate (Sigma), pH 2.2; buffer B,
0.15 M sodium citrate, pH 3.0; gradient of 100% A for min 0 to 11, 0 to 37% B for min 11 to 20, 37 to 100% B for min 20 to 25, 100% B for
min 25 to 35, 100 to 0% B for min 35 to 36, and 100% A for min 36 to
45. The areas for the citrulline peaks were calculated and normalized
against the glucosamine peak.
RT-PCR analysis of NOS1, NOS2, and NOS3 gene expression.
RNA
was extracted with Tri-reagent according to the manufacturer's
instructions (Sigma) from HL-60 cells or from primary human umbilical
endothelial cells (HUVECs), kindly provided by Kathy Makepeace. Reverse
transcription was carried out with the RAP-PCR kit (Stratagene,
Cambridge, United Kingdom) with oligo(dT)18 primer as per
the manufacturer's instructions. PCR amplification of cDNA was with 2 µl of cDNA, 1 µM each primer (see below), 1.8 mM MgCl2 (Boehringer Mannheim), 1× PCR buffer (Perkin-Elmer, Applied
Biosystems, Warrington, United Kingdom), and 0.05 U of Taq-Gold
(Perkin-Elmer) per µl in a total volume of 20 µl. Thermal cycling
was as follows: 1 cycle of 94°C for 12 min and 55°C for 5 min; 35 cycles of 72°C for 2 min, 94°C for 1 min, and 55°C for 1 min; and
1 cycle of 72°C for 10 min. PCR products were separated on 1.2%
agarose (Gibco, Paisley, United Kingdom) gels containing 1 µg of
ethidium bromide (Sigma) per ml in 1× TAE buffer (Gibco) and viewed
and photographed digitally under UV light with the Image Store 5000 system (UVP Life Sciences, Cambridge, United Kingdom). A 100-bp ladder
(Gibco) was used for markers. NOS1 primers were
5'-GAATACCAGCCTGATCCCTGGAA-3' and
5'-TCCAGGAGGGTGTCCACAGCGTG-3' (599-bp product), based on the human GenBank sequence U17327 and analogous to the rat NOS1 primers
described previously (19). NOS2 primers were
5'-TCCGAGGCAAACAGCACATTCA-3' (31) and
5'-GATATCTTCGTGATAGCGCTTCTGGC-3' (1,325-bp product). NOS3
primers were 5'-GTGATGGCGAAGCGAGTGAAG-3' and
5'-CCGAGCCCGAACACACAGAAC-3' (422-bp product)
(31). GAPDH (glyceraldehyde-3-phosphate dehydrogenase) primers were 5'-CCACCCATGGCAAATTCCATGGGA-3' and
5'-TCTAGACGGCAGGTCAGGTCCACC-3' (598-bp product).
Northern analysis of NOS2 gene expression.
Total cellular
RNA was prepared by using Tri-reagent (Sigma). RNA (10 µg per sample)
was separated on a 1.4% agarose-1.8 M formaldehyde gel and
transferred to a nylon membrane (Hybond N+; Amersham). This was
hybridized with a 32P-labelled human NOS2 DNA fragment
containing nucleotides 2813 to 3587. (This probe was generated by
RT-PCR of RNA from MonoMac6 cells stimulated with LPS plus PMA, using
primers 5'-CAAGTGGAAGTTCACCAACAGC-3' and
5'-GATATCTTCGTGATAGCGCTTCTGGC-3'; the PCR product was cloned and found to match the published NOS2 gene sequence from human hepatocytes [Genbank accession no. L09210]). The membrane was then
washed and exposed to X-ray film (Amersham), and the image was recorded
digitally before analysis with Image Quant software (Molecular Dynamics
Ltd., Kemsing, United Kingdom) without any enhancement. To allow for
potential loading differences between lanes, the amount of NOS2 mRNA
was compared with that of
-actin mRNA or with the total amount of
RNA applied to the gel as determined by ethidium bromide staining.
M. tuberculosis experiments.
M.
tuberculosis bacilli (strain H37Rv) were thawed from frozen stock,
briefly sonicated, and incubated with HL-60hca (5 CFU/cell) at 37°C for 3 h in 500 µl of culture medium. The medium was
the same as described above for HL-60 culture, except that ampicillin (100 µg/ml) was substituted for streptomycin and penicillin. The cells were washed three times in Dulbecco modified Eagle medium to
remove noningested bacilli and resuspended at 106 cells/ml,
and 2 ml was incubated in upright 25-cm2 tissue culture
flasks in a humidified incubator at 37°C in a 5% CO2
atmosphere. Where appropriate, 1,25-D3 (2 × 10
8 M) and L-NMMA (1 mM) were added to the
culture medium. After 6 days (immediately after maximal NO production
[see Results]), the entire contents of each flask were harvested by
centrifugation at 1,000 × g for 15 min, and the
supernatants were collected, filter sterilized (0.22 µm), and frozen
until assayed for RNI. The remaining cell pellets were lysed in water,
and the viable bacilli were estimated by plating in serial dilutions on
Middlebrook 7H10 agar supplemented with oleic acid, albumin fraction V,
dextrose, and catalase (all from Difco Laboratories, East Molesey,
United Kingdom). The plates were sealed in bags and incubated at 36°C for 2 to 3 weeks before M. tuberculosis CFU were enumerated
with an Anderman colony counter. Results from individual experiments were expressed as a percentage of the CFU in unstimulated
HL-60hca cells before calculation of means of data from
several experiments. Nonparametric statistics (Wilcoxon matched-pairs
signed rank test) were used to compare differences between groups.
 |
RESULTS |
Initial characterization of the HL-60hca cell
line.
When HL-60 cells were cultured continuously at 7.5%
CO2 in standard growth media without inducing factors, it
was noted that a significant proportion of cells became adherent to the
plastic tissue culture flask in the absence of any observable pH change to the medium when compared to cells kept at 5% CO2. After
approximately eight cycles of selection by removal of nonadherent
cells, it was found that the majority of cells were adherent and that
this attribute was preserved after storage in liquid nitrogen. The cells became nonadherent within a week of reduction of the
CO2 concentration to 5%, but adherence was restored within
a few days of return to 7.5% CO2. We have termed this
high-CO2 adherent line HL-60hca.
The following phenotypic properties were observed for both unstimulated
and LPS-stimulated HL-60hca cells. They adhered to plastic.
After 2 h of incubation with nonopsonized latex particles, phagocytosis was seen in >50% of cells. NBT reduction was observed in
<5% of cells. As determined by fluorescence microscopy and by
fluorescence-activated cell sorter analysis, they expressed surface
CD14 but not CD23. LPS-stimulated cells, but not unstimulated cells,
gave a positive NADPH-diaphorase reaction that was inhibited by 1 mM
L-NMMA. Taken together with the published literature on HL-60 differentiation pathways (2, 3, 11), these results indicate that the HL-60hca cell line is essentially
macrophage-like.
Results of initial experiments on RNI production by the parent HL-60
cells are shown in Fig.
1a. As previously
described (
40),
stimulation with 100 ng of LPS per ml had
little effect on its
own, but in combination with 10 ng of PMA per ml
it elicited 5.6
µM RNI after 2 days in culture. In contrast,
HL-60
hca cells produced
18.2 µM RNI after stimulation
with LPS alone, and this response
was not significantly boosted by the
addition of PMA (Fig.
1b).
The latter response was inhibited by
L-NMMA (50% inhibitory concentration
~150 µM) in a
dose-dependent manner (Fig.
1c) but not by
D-NMMA
(data not
shown). This result suggested that the rise in RNI levels
was due to
NOS activity.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
RNI production by original HL-60 cells (a) and
HL-60hca cells (b). Cells (105 in 100 µl of
medium) were stimulated for 48 h with medium alone
( ), LPS
(100 ng/ml) ( ), PMA (10 ng/ml)
( ), or LPS (100 ng/ml)
plus PMA (10 ng/ml) ( ).
(c) Inhibitory effect of L-NMMA on RNI production by
HL-60hca cells after 6 days of stimulation with LPS (100 ng/ml) ( ). , background level of RNI production by unstimulated
cells. Data are means ± SEMs for three experiments in each
case.
|
|
Kinetics of nitric oxide production.
To assess the kinetics of
the inducible response, 100 ng of LPS per ml was added to wells
containing 3 × 106 HL-60hca cells in 2 ml
of culture medium. To minimize the effect of nutrient starvation, 10%
of the medium plus LPS was replaced each day, and estimates of
cumulative RNI production were corrected accordingly (the amount of RNI
removed each day was measured and added to the cumulative total).
Supernatants were assayed for RNI by using Griess reagent. The
accumulated level of RNI rose significantly after 2 days and reached a
plateau of 20 µM at 7 to 8 days after stimulation (Fig.
2a). The daily rate of NO production is
reflected in the rate of conversion of
L-[14C]arginine to
L-[14C]citrulline, which rose significantly
within 2 days, reached a peak at 5 to 6 days, and fell to baseline
levels by day 10 after stimulation (Fig. 2b). This decline did not
appear to be attributable to loss of cell viability, since over 60% of
cells were viable as determined by the trypan blue exclusion test when
assessed on day 16.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
(a) Accumulation of RNI with time in culture wells
containing 3 × 106 HL-60hca cells in 2 ml
of medium stimulated with LPS (100 ng/ml). Data represent means ± SEMs for nine experiments. (b) Daily rate of
[14C]citrulline formation from
[14C]arginine, using 1.5 × 105 cells
per well containing 100 µl of medium and stimulated with 100 ng of
LPS per ml. Results are means ± SEMs for six experiments.
|
|
Evidence for inducible NOS2 gene expression.
Taken
together, these findings strongly suggest that
HL-60hca cells possess inducible NOS activity, namely, that
LPS stimulates arginine-to-citrulline conversion accompanied by
generation of RNI (which is inhibitable by L-NMMA) and a
positive NADPH-diaphorase reaction. To investigate this further, we
used RT-PCR to examine expression of the genes for the three common NOS
isoforms following LPS stimulation of HL-60hca cells.
HUVECs were used as a positive control for the constitutive forms of
NOS, i.e., neuronal NOS (the product of the NOS1 gene) and endothelial
NOS (the product of the NOS3 gene). The authenticities of the PCR
products assigned as NOS1 and NOS3 in HUVECs and of that assigned as
NOS2 in HL-60hca cells were verified by cloning and
sequencing of the respective PCR products. As shown in Fig.
3a, NOS2 expression was detected in
HL-60hca cells at 24 and 96 h following LPS
stimulation but was absent in unstimulated HL-60hca cells
and in HUVEC controls. In contrast, NOS1 and NOS3 were constitutively
expressed in HUVEC controls but not in HL-60hca cells,
although a NOS3-like band was observed in HL-60hca cells at
96 h after LPS stimulation. To assess the kinetics of the
inducible NOS2 response in HL-60hca cells, we performed a
semiquantitative Northern analysis (Fig. 3b). A single band of 4.5 kb
was observed and indicated that NOS2 mRNA expression starts to rise
within 3 h (in agreement with the data of Linn et al.
[22]), reaches a plateau by about 12 h, and is
maintained for at least 16 days after LPS stimulation (Fig. 3b).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 3.
(a) RT-PCR for NOS1 (lanes 1), NOS2 (lanes 2), NOS3
(lanes 3), or a GAPDH control (lanes G) with RNA extracted from
HL-60hca cells stimulated with LPS (100 ng/ml) for 0, 24, or 96 h and from unstimulated HUVEC controls. (b) Northern
analysis of NOS2 gene expression in HL-60hca cells after
various durations of stimulation with LPS (100 ng/ml). Kinetics over
the first 24 h are shown by the graph, representing the ratio of
NOS2 mRNA to -actin mRNA as quantitated on a digital image as
described in text. Longer kinetics are depicted in the inset, which
compares NOS2 mRNA (Northern blot) with total RNA stained with ethidium
bromide (EtBr). The molecular size of the NOS2 band is approximately
4.5 kb.
|
|
Induction of NO production by vitamin D.
1,25-D3
has been previously used to differentiate HL-60 cells (11),
and it has been reported that the combination of 1,25-D3 plus prostaglandin E1 stimulates NO production in this cell
line (20). To examine the effect of vitamin D on NO
production by HL-60hca cells, 2.5 × 105
cells in 100 µl of medium were stimulated for 6 days with
1,25-D3, ergocalciferol, or cholecalciferol at various
doses. As shown in Fig. 4a,
1,25-D3 at nanomolar concentrations without other costimuli
induced NO production in HL-60hca cells. With 10 nM 1,25-D3, the level of RNI production was approximately 60%
of that seen in response to 100 ng of LPS per ml. In contrast, neither ergocalciferol nor cholecalciferol induced a significant RNI response when tested at concentrations as high as 10 µM. It is important to
note that DMSO did not affect LPS-induced NO production when tested at
the concentrations used to maintain vitamin D analogues in solution
(data not shown) and that we were able to rule out LPS contamination of
the 1,25-D3 by using several different batches of the
compound and finding that it did not stimulate tumor necrosis factor
production from HL-60hca and other macrophage cell lines, nor have we found 1-25 D3 alone to stimulate the parent
cell line (data not shown).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 4.
(a) Induction of RNI in HL-60hca cells after
6 days of stimulation with 1,25-D3 ( ), ergocalciferol
( ), or cholecalciferol ( ). Filled circles denote experimental
controls with medium alone, LPS (100 ng/ml), or LPS (100 ng/ml) plus
L-NMMA (1 mM). Data points are means ± SEMs from four
experiments. (b) RT-PCR for NOS1 (lanes 1), NOS2 (lanes 2), NOS3 (lanes
3), or a GAPDH control (lanes G) with RNA extracted from
HL-60hca cells stimulated with 10 8 M
1,25-D3 LPS for 0, 24, or 96 h and from unstimulated
HUVEC controls.
|
|
As part of the RT-PCR analysis described for Fig.
3a, we examined NOS1,
NOS2, and NOS3 gene expression following stimulation
with
1,25-D
3. NOS2 mRNA was not detected in unstimulated cells
but was weakly expressed at 24 h and strongly expressed at 96
h after stimulation. NOS1 and NOS3 gene expression was not detected
following 1,25-D
3 stimulation (Fig.
4b).
Effect of 1,25-D3 on M. tuberculosis in
HL-60hca cells.
Electron microscopy demonstrated the
ability of HL-60hca cells to ingest M. tuberculosis (Fig. 5). Light
microscopy (Ziehl-Neelson stain) and fluorescence microscopy (auramine
stain) indicated that on the order of 10% of cells were infected after
3 h of incubation at 37°C with 5 CFU/cell (data not shown). To
test the hypothesis that NO induced by vitamin D might suppress the
viability and/or growth of M. tuberculosis in these cells,
approximately 2 × 106 HL-60hca cells
infected with M. tuberculosis were cultured for 6 days in
the presence of 1,25-D3 (20 nM), L-NMMA (1 mM),
1,25-D3 plus L-NMMA, or neither of these
compounds. In a series of six experiments, the geometric mean number of
bacilli recovered after 6 days from control cultures without
1,25-D3 or L-NMMA was 3.3 × 105 CFU (95% confidence interval, 0.8 × 105 to 14 × 105 CFU), and the mean RNI
concentration was 2.2 µM (standard error of the mean [SEM], 0.7).
Because of the variability between experiments, the number of CFU or
the RNI concentration recovered from cells treated with
1,25-D3 or L-NMMA was analyzed as a percentage
of the recovery from control cultures. As shown in Table
1, cultures containing
1,25-D3 showed a significant reduction in the number of
bacilli recovered at 6 days (P = 0.02 by the Wilcoxon
matched-pairs signed rank test) and a significant increase in the level
of RNI (P = 0.015) compared to control cultures. Both
of these effects of 1,25-D3 were inhibited by the addition
of L-NMMA; i.e., recovered CFU were significantly higher
(P = 0.03) and RNI levels were significantly lower
(P = 0.02) in cultures treated with 1,25-D3
plus L-NMMA compared to those treated with
1,25-D3 alone. L-NMMA on its own had little
effect on RNI levels or on the number of CFU recovered at 6 days,
compared to control cultures.

View larger version (120K):
[in this window]
[in a new window]
|
FIG. 5.
Electron transmission micrograph of HL-60hca
cells, demonstrating infection with M. tuberculosis after 3 days of culture. Magnifications, ×16,500 (left panel) and ×32,500
(right panel). N, HL-60hca cell nucleus. Arrows point to
mycobacteria.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Effect of 1,25-D3 and L-NMMA on
RNI production and recovery of M. tuberculosis from
HL-60hca cells after 6 days of culture
|
|
 |
DISCUSSION |
The HL-60hca cell line has several notable features.
The NOS2 gene is expressed, and high levels of nitric oxide are
generated following stimulation with LPS or 1,25-D3. This
unusual degree of NO inducibility is of particular interest since the
cells have a macrophage-like phenotype. Our data indicate that
1,25-D3 acts to inhibit the growth or viability of M. tuberculosis in HL-60hca cells through an NO-dependent
mechanism.
It is puzzling that human macrophages generally fail to produce NO in
response to stimuli such as LPS plus gamma interferon in vitro,
considering the critical role of NO in defending mouse macrophages
against a variety of intracellular pathogens. Since NOS2 expression has
been demonstrated in pulmonary alveolar macrophages from humans with
tuberculosis, it is conceivable that inducible NO synthesis in humans
depends on specific processes of macrophage differentiation in vivo
(27). HL-60 is a human promyelocytic cell line which can be
induced to differentiate in various ways: for example, a
monocyte/macrophage-like phenotype can be induced by vitamin D or gamma
interferon, whereas neutrophil- or eosinophil-like phenotypes are
induced by DMSO or alkaline media, respectively (11). The
undifferentiated parent cell line is nonadherent, and the present
investigation stems from our chance observation that a significant
proportion of the cells spontaneously became adherent after several
weeks in culture at 7.5% CO2, allowing us to select an
adherent line that we have termed HL-60hca. The adherent
properties of HL-60hca cells appear to depend on continual high CO2 concentration, but we cannot exclude the
possibility that unknown factors have contributed to differentiation of
this phenotype. Importantly, adherence is preserved after storage in liquid nitrogen. HL-60hca cells express CD14 and readily
phagocytose latex particles, whereas they do not reduce NBT. They also
ingest M. tuberculosis. Taking these findings together with
the published literature on HL-60 differentiation pathways (2, 3,
11), we conclude that the HL-60hca line is
essentially macrophage-like.
A striking feature of HL-60hca cells is that LPS alone is
sufficient to induce NO production. This contrasts with the case for
undifferentiated HL-60 cells, which require more complex combinations of stimuli to produce NO (20, 37, 40). Our data confirm that
the parent HL-60 cell line can produce NO after stimulation with PMA
and LPS in combination but not with either agent alone. Levels of RNI
in the culture supernatant of LPS-stimulated HL-60hca cells
can reach almost half the levels obtained from murine macrophages optimally stimulated with LPS plus gamma interferon (34).
Several lines of evidence indicate that the LPS-induced NO response in
HL-60hca cells is due to activity of an NOS, which we
identify as NOS2. Diaphorase activity is present in LPS-stimulated but
not in unstimulated cells, and both this and the inducible rise in RNI
are inhibited by L-NMMA. Following LPS stimulation, there
is a marked rise in the rate of formation of
[14C]citrulline from [14C]arginine, whose
time course is consistent with the rate of accumulation of RNI in the
culture medium. RT-PCR of LPS-stimulated cells yields a product,
confirmed as human NOS2 by sequencing, which is absent in the
unstimulated state. Northern analysis confirms that levels of NOS2 mRNA
rise appreciably after LPS stimulation. Taking these data together, we
can exclude the possibility that the accumulation of RNI is simply due
to alternate mechanisms, as has been recently proposed for other
experimental systems involving cultured human macrophages (38,
39).
Our time course experiments with HL-60hca cells suggest
that the relationship between NOS2 mRNA expression and the rate of NO
production is complex. Both Northern and RT-PCR analyses show that
levels of NOS2 mRNA rise markedly within 12 h and are maintained for at least 14 days after stimulation with LPS. The daily rate of
conversion of arginine to citrulline rises significantly during the 2nd
day, reaches a peak during the 5th and 6th days, and declines to
resting levels on the 10th day after stimulation. Consistent with the
latter observation, the amount of RNI in the culture medium rises
progressively for 7 or 8 days and thereafter remains more or less
constant. That is, high levels of NOS2 mRNA are accompanied by
increasing rates of NO generation in the first few days, but after day
6 the rate of NO generation declines while NOS2 mRNA levels remain
high. The decline does not appear to be due to nutrient depletion,
since we replaced 10% of the culture supernatant with fresh medium
every 24 h, and a similar time course was observed in experiments
where the medium was not replaced (data not shown). In other
experimental contexts it has been found that NO generation can remain
low despite high levels of NOS2 mRNA and NOS2 protein (31),
and there is growing evidence of mechanisms that can modulate the
functional activity of NO synthases (17, 19). Thus, it is
interesting to speculate that the eventual decline in rates of NO
generation in LPS-induced HL-60hca cells might be caused by
autoregulatory processes on NOS2 gene expression (1, 10, 26, 29,
32), and further investigation of this phenomenon is warranted.
It is well known that vitamin D has potent immunomodulatory
properties (6), but little attention has been paid to the
possibility that one of its important immunological functions may be to
enhance expression of the NOS2 gene, despite a previous report that
undifferentiated HL-60 cells produce NO when stimulated with a
combination of 1,25-D3 plus prostaglandin E1
(20). We find that 1,25-D3 stimulates HL-60hca cells to express NOS2 mRNA and generate NO,
whereas cholecalciferol and ergocalciferol do not. The ability of
1,25-D3 to stimulate a detectable NO output at
concentrations as low as 1 nM suggests that the observed effects are
physiologically plausible. The concentration of 1,25-D3 in
normal human serum is around 0.1 nM, but that of its immediate
precursor 25-hydoxyvitamin D3 is around 100 nM
(12). A critical point is that 25-hydroxyvitamin
D3 is converted to 1,25-D3 within the
macrophage, and the rate of conversion increases markedly within
pulmonary alveolar macrophages and human monocytes following
stimulation with gamma interferon (21, 36).
The last observation may be highly relevant to the role of NO in the
host defense against human tuberculosis. Although gene knockout
experiments with mice have formally identified the NOS2 gene as a
potentially important component of the host defense against
tuberculosis (24), whether human macrophages can produce NO
at antimicrobial concentrations remains controversial (15). NOS2 protein is expressed in pulmonary alveolar macrophages from tuberculous patients (27), raising the possibility that the natural NO response in human tuberculosis depends on factors that have
not been adequately explored in vitro. Several lines of evidence point
to vitamin D as one of the missing factors. There is a substantial body
of circumstantial clinical evidence that vitamin D is protective against human tuberculosis (4, 25, 35), and we have recently found that polymorphisms in the vitamin D receptor gene are associated with susceptibility to pulmonary tuberculosis in an African population (1a). 1,25-D3 suppresses the growth of M. tuberculosis in human monocyte-derived macrophages (13,
36). Taking these observations together with the present data, we
can speculate that 1,25-D3 acts to control tuberculosis in
human macrophages by an NO-dependent mechanism.
Our observations on the growth of M. tuberculosis in
HL-60hca cells support this proposition. The number of CFU
recovered from HL-60hca cells 6 days after infection was
significantly reduced as a result of adding 20 nM 1,25-D3
to the culture medium, and the level of RNI generation was increased.
Both of these effects of 1,25-D3 were reversed by the
addition of L-NMMA. However, L-NMMA had no
effect on the recovery of M. tuberculosis or RNI generation compared to control cultures without 1,25-D3. Taken
together, these results indicate that ingestion of M. tuberculosis does not directly stimulate HL-60hca
cells to produce NO but that cells stimulated with 1,25-D3
inhibit M. tuberculosis via a mechanism that involves NO
production.
Several important questions arise from these observations. Are there
specific differentiation processes and costimulatory factors that
permit 1,25-D3 to induce NOS2 gene expression in natural
human macrophages? Is gamma interferon the major stimulus for
intracellular generation of 1,25-D3, and thereby NO, in the pulmonary alveolar macrophages of humans with tuberculosis, or are
there other important immune stimuli? How does NO suppress the
intracellular growth of M. tuberculosis; i.e., does it act directly on the microbe, affecting its survival or its ability to
replicate, or is the suppression an indirect consequence of metabolic
changes in the host cell that are caused by NO? The HL-60hca cell line provides a tool for exploring these
issues and the general question of how the human NOS2 gene is
regulated.
 |
ACKNOWLEDGMENTS |
This work was supported by the Wellcome Trust and The Medical
Research Council.
We thank Andrew Skinner for electron microscopy, the Public Health
Laboratory Service of the John Radcliffe Hospital for category 3 facilities, and Warrick Britton, Mycobacterial Research Group, Centenary Institute of Cancer Medicine and Cell Biology, Sydney, Australia, for helpful discussion and advice.
The first two authors contributed equally to this work.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University
Department of Paediatrics, John Radcliffe Hospital, Oxford OX3
9DU, United Kingdom. Phone: 1865-221061. Fax: 1865-220479. E-mail: krockett{at}hammer.imm.ox.ac.uk.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Assreuy, J.,
F. Q. Cunha,
F. Y. Liew, and S. Moncada.
1993.
Feedback inhibition of nitric oxide synthase activity by nitric oxide.
Br. J. Pharmacol.
108:833-837[Medline].
|
| 1a.
| Bellamy, R., A. V. S. Hill, et al.
Unpublished data.
|
| 2.
|
Bober, L. A.,
T. A. Waters,
C. C. Pugliese Sivo,
L. M. Sullivan,
S. K. Narula, and M. J. Grace.
1995.
IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils.
Clin. Exp. Immunol.
99:129-136[Medline].
|
| 3.
|
Brackman, D.,
F. Lund Johansen, and D. Aarskog.
1995.
Expression of leukocyte differentiation antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells.
J. Leukoc. Biol.
58:547-555[Abstract].
|
| 4.
|
Brincourt, J.
1967.
Le calcifél a-t-il une action liquéfiante sur le caséum.
Le poumon et la coeur
23:841-851.
|
| 5.
|
Bukrinsky, M. I.,
H. S. Nottet,
H. Schmidtmayerova,
L. Dubrovsky,
C. R. Flanagan,
M. E. Mullins,
S. A. Lipton, and H. E. Gendelman.
1995.
Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease.
J. Exp. Med.
181:735-745[Abstract/Free Full Text].
|
| 6.
|
Casteels, K.,
R. Bouillon,
M. Waer, and C. Mathieu.
1995.
Immunomodulatory effects of 1,25-dihydroxyvitamin D3.
Curr. Opin. Nephrol. Hyperten.
4:313-318[Medline].
|
| 7.
|
Chan, J.,
K. Tanaka,
D. Carroll,
J. Flynn, and B. R. Bloom.
1995.
Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis.
Infect. Immun.
63:736-740[Abstract].
|
| 8.
|
Chenais, B.,
A. Yapo,
M. Leppoivre, and J. P. Tenu.
1991.
High performance liquid chromatographic analysis of the unusual pathway of oxidation of L-arginine to citrulline and nitric oxide in mammalian cells.
J. Chromatogr.
539:433-441[Medline].
|
| 9.
|
Clark, I. A., and K. A. Rockett.
1996.
Nitric oxide and parasitic disease, p. 1-56.
In
B. Dawer (ed.), Advances in parasitology. Academic Press, London, United Kingdom.
|
| 10.
|
Colasanti, M.,
T. Persichini,
M. Menegazzi,
S. Mariotto,
E. Giordano,
C. M. Caldarera,
V. Sogos,
G. M. Lauro, and H. Suzuki.
1995.
Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide.
J. Biol. Chem.
270:26731-26733[Abstract/Free Full Text].
|
| 11.
|
Collins, S. J.
1987.
The HL-60 promyelocytic cell line: proliferation, differentiation, and cellular oncogene expression.
Blood
70:1233-1244[Abstract/Free Full Text].
|
| 12.
|
Combs, G. F.
1992.
The vitamins: fundamental aspects in nutrition and health, p. 151-177.
Academic Press, London, United Kingdom.
|
| 13.
|
Crowle, A. J.,
E. J. Ross, and M. H. May.
1987.
Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages.
Infect. Immun.
55:2945-2950[Abstract/Free Full Text].
|
| 14.
|
De Maria, R.,
M. G. Cifone,
R. Trotta,
M. R. Rippo,
C. Festuccia,
A. Santoni, and R. Testi.
1994.
Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors.
J. Exp. Med.
180:1999-2004[Abstract/Free Full Text].
|
| 15.
|
Denis, M.
1994.
Human monocytes/macrophages: NO or no NO?
J. Leukoc. Biol.
55:682-684[Abstract].
|
| 16.
|
Green, S. J.,
L. F. Scheller,
M. A. Marletta,
M. C. Seguin,
F. W. Klotz,
M. Slayter,
B. J. Nelson, and C. A. Nacy.
1994.
Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens.
Immunol. Lett.
43:87-94[Medline].
|
| 17.
|
Griffith, O. W., and S. S. Gross.
1996.
Inhibitors of nitric oxide inhibitors, p. 187-208.
In
M. Feelisch, and J. S. Stamler (ed.), Methods in nitric oxide research John Wiley and Sons, Chichester, United Kingdom.
|
| 18.
|
Hon, W. M.,
V. J. S. Chhatwal,
H. E. Khoo, and S. M. Moochhala.
1997.
Histochemical method for detecting nitric oxide synthase activity in cell cultures.
Biotechnic. Histochem.
72:29-32[Medline].
|
| 19.
|
Jaffrey, S. R., and S. H. Snyder.
1996.
PIN: an associated protein inhibitor of neuronal nitric oxide synthase.
Science
274:774-777[Abstract/Free Full Text].
|
| 20.
|
Kawase, T.,
S. Ogata,
M. Orikasa, and D. M. Burns.
1995.
1,25-Dihydroxyvitamin D3 promotes prostaglandin E1-induced differentiation of HL-60 cells.
Calcif. Tissue Int.
57:359-66[Medline].
|
| 21.
|
Koeffler, H. P.,
H. Reichel,
J. E. Bishop, and A. W. Norman.
1985.
-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages.
Biochem. Biophys. Res. Commun.
127:596-603[Medline].
|
| 22.
|
Linn, S. C.,
P. J. Morelli,
I. Edry,
S. E. Cottongim,
C. Szabo, and A. L. Salzman.
1997.
Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line.
Am. J. Physiol.
272:G1499-G1508[Abstract/Free Full Text].
|
| 23.
|
Macmicking, J. D.,
C. Nathan,
G. Hom,
N. Chartrain,
D. S. Fletcher,
M. Trumbauer,
K. Stevens,
Q. W. Xie,
K. Sokol,
N. Hutchinson,
H. Chen, and J. S. Mudgett.
1995.
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.
Cell
81:641-650[Medline].
|
| 24.
|
Macmicking, J. D.,
R. J. North,
R. Lacourse,
J. S. Mudgett,
S. K. Shah, and C. F. Nathan.
1997.
Identification of nitric oxide synthase as a protective locus against tuberculosis.
Proc. Natl. Acad. Sci. USA
94:5243-5248[Abstract/Free Full Text].
|
| 25.
|
Macrae, D.
1947.
Calciferol treatment in lupus vulgaris.
Br. J. Dermatol.
59:333-338.
|
| 26.
|
Matthews, J. R.,
C. H. Botting,
M. Panico,
H. R. Morris, and R. T. Hay.
1996.
Inhibition of NF-kappaB DNA binding by nitric oxide.
Nucleic Acids Res.
24:2236-2242[Abstract/Free Full Text].
|
| 27.
|
Nicholson, S.,
M. D. G. Bonecini Almeida,
J. R. Lapa e Silva,
C. Nathan,
Q. W. Xie,
R. Mumford,
J. R. Weidner,
J. Calaycay,
J. Geng,
N. Boechat,
C. Linhares,
W. Rom, and J. L. Ho.
1996.
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.
J. Exp. Med.
183:2293-2302[Abstract/Free Full Text].
|
| 28.
|
Nozaki, Y.,
H. Yoshinori,
S. Ichiyama,
I. Nakahima, and K. Shimokata.
1997.
Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages.
Infect. Immun.
65:3644-3647[Abstract].
|
| 29.
|
Park, S. K.,
H. L. Lin, and S. Murphy.
1997.
Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappa b binding to DNA.
Biochem. J.
322:609-613.
|
| 30.
|
Patthy, A.,
S. Bajusz, and L. Patthy.
1977.
Preparation and characterisation of NG-mono-, di-, and trimethylated arginines.
Acta Biochim. Biophys. Acad. Sci. Hung
12:191-195[Medline].
|
| 31.
|
Reiling, N.,
A. J. Ulmer,
M. Duchrow,
M. Ernst,
H. D. Flad, and S. Hauschildt.
1994.
Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages.
Eur. J. Immunol.
24:1941-1944[Medline].
|
| 32.
|
Rengasamy, A., and R. A. Johns.
1993.
Regulation of nitric oxide synthase by nitric oxide.
Mol. Pharmacol.
44:124-128[Abstract].
|
| 33.
|
Rhoades, E. R., and I. M. Orme.
1997.
Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates.
Infect. Immun.
65:1189-1195[Abstract].
|
| 34.
|
Rockett, K. A.,
D. Kwiatkowski,
C. A. W. Bate,
M. M. Awburn,
E. J. Rockett, and I. A. Clark.
1996.
In vitro induction of nitric oxide by an extract of plasmodium falciparum.
J. Infect.
32:187-196[Medline].
|
| 35.
|
Rook, G. A.
1988.
The role of vitamin D in tuberculosis.
Am. Rev. Respir. Dis.
138:768-770[Medline].
|
| 36.
|
Rook, G. A.,
J. Steele,
L. Fraher,
S. Barker,
R. Karmali,
J. O'Riordan, and J. Stanford.
1986.
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes.
Immunology
57:159-163[Medline].
|
| 37.
|
Schmidt, H. H.,
R. Seifert, and E. Bohme.
1989.
Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor and leukotriene B4.
FEBS Lett.
244:357-360[Medline].
|
| 38.
|
Schneemann, M.,
G. Schoedon,
P. Linscheid,
R. Walter,
N. Blau, and A. Schaffner.
1997.
Nitrite generation in interleukin-4-treated human macrophage cultures does not involve the nitric oxide synthase pathway.
J. Infect. Dis.
175:130-135[Medline].
|
| 39.
|
Singh, R.,
S. Pervin,
N. E. Rogers,
L. J. Ignarro, and G. Chaudhuri.
1997.
Evidence for the presence of an unusual nitric oxide- and citrulline-producing enzyme in rat kidney.
Biochem. Biophys. Res. Commun.
232:672-677[Medline].
|
| 40.
|
Tsuda, H., and M. Hasegawa.
1990.
Malignant transformation of mouse BALB/c3T3 cells induced by NaNO2.
Carcinogenesis
11:595-597[Abstract/Free Full Text].
|
| 41.
|
Vouldoukis, I.,
V. Riverosmoreno,
B. Dugas,
F. Ouaaz,
P. Becherel,
P. Debre,
S. Moncada, and M. D. Mossalayi.
1995.
The killing of leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the fc epsilon RII/CD23 surface antigen.
Proc. Natl. Acad. Sci. USA
92:7804-7808[Abstract/Free Full Text].
|
Infection and Immunity, November 1998, p. 5314-5321, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Moeenrezakhanlou, A., Shephard, L., Lam, L., Reiner, N. E.
(2008). Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase. J. Leukoc. Biol.
84: 519-528
[Abstract]
[Full Text]
-
Sita-Lumsden, A, Lapthorn, G, Swaminathan, R, Milburn, H J
(2007). Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax
62: 1003-1007
[Abstract]
[Full Text]
-
Martineau, A. R., Wilkinson, R. J., Wilkinson, K. A., Newton, S. M., Kampmann, B., Hall, B. M., Packe, G. E., Davidson, R. N., Eldridge, S. M., Maunsell, Z. J., Rainbow, S. J., Berry, J. L., Griffiths, C. J.
(2007). A Single Dose of Vitamin D Enhances Immunity to Mycobacteria. Am. J. Respir. Crit. Care Med.
176: 208-213
[Abstract]
[Full Text]
-
Martineau, A. R., Wilkinson, K. A., Newton, S. M., Floto, R. A., Norman, A. W., Skolimowska, K., Davidson, R. N., Sorensen, O. E., Kampmann, B., Griffiths, C. J., Wilkinson, R. J.
(2007). IFN-{gamma}- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-37. J. Immunol.
178: 7190-7198
[Abstract]
[Full Text]
-
Foote, M. R., Nonnecke, B. J., Beitz, D. C., Waters, W. R.
(2007). High Growth Rate Fails to Enhance Adaptive Immune Responses of Neonatal Calves and Is Associated with Reduced Lymphocyte Viability. J DAIRY SCI
90: 404-417
[Abstract]
[Full Text]
-
Ludvigsson, J F, Wahlstrom, J, Grunewald, J, Ekbom, A, Montgomery, S M
(2007). Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax
62: 23-28
[Abstract]
[Full Text]
-
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., Kamen, D. L., Wagner, M., Bals, R., Steinmeyer, A., Zugel, U., Gallo, R. L., Eisenberg, D., Hewison, M., Hollis, B. W., Adams, J. S., Bloom, B. R., Modlin, R. L.
(2006). Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response. Science
311: 1770-1773
[Abstract]
[Full Text]
-
Helming, L., Bose, J., Ehrchen, J., Schiebe, S., Frahm, T., Geffers, R., Probst-Kepper, M., Balling, R., Lengeling, A.
(2005). 1{alpha},25-dihydroxyvitamin D3 is a potent suppressor of interferon {gamma}-mediated macrophage activation. Blood
106: 4351-4358
[Abstract]
[Full Text]
-
Bendall, J. K., Alp, N. J., Warrick, N., Cai, S., Adlam, D., Rockett, K., Yokoyama, M., Kawashima, S., Channon, K. M.
(2005). Stoichiometric Relationships Between Endothelial Tetrahydrobiopterin, Endothelial NO Synthase (eNOS) Activity, and eNOS Coupling in Vivo: Insights From Transgenic Mice With Endothelial-Targeted GTP Cyclohydrolase 1 and eNOS Overexpression. Circ. Res.
97: 864-871
[Abstract]
[Full Text]
-
Buettner, M., Meinken, C., Bastian, M., Bhat, R., Stossel, E., Faller, G., Cianciolo, G., Ficker, J., Wagner, M., Rollinghoff, M., Stenger, S.
(2005). Inverse Correlation of Maturity and Antibacterial Activity in Human Dendritic Cells. J. Immunol.
174: 4203-4209
[Abstract]
[Full Text]
-
Holten-Andersen, L., Doherty, T. M., Korsholm, K. S., Andersen, P.
(2004). Combination of the Cationic Surfactant Dimethyl Dioctadecyl Ammonium Bromide and Synthetic Mycobacterial Cord Factor as an Efficient Adjuvant for Tuberculosis Subunit Vaccines. Infect. Immun.
72: 1608-1617
[Abstract]
[Full Text]
-
Rhodes, S. G., Terry, L. A., Hope, J., Hewinson, R. G., Vordermeier, H. M.
(2003). 1,25-Dihydroxyvitamin D3 and Development of Tuberculosis in Cattle. CVI
10: 1129-1135
[Abstract]
[Full Text]
-
Venketaraman, V., Dayaram, Y. K., Amin, A. G., Ngo, R., Green, R. M., Talaue, M. T., Mann, J., Connell, N. D.
(2003). Role of Glutathione in Macrophage Control of Mycobacteria. Infect. Immun.
71: 1864-1871
[Abstract]
[Full Text]
-
Morris, K. R., Lutz, R. D., Choi, H.-S., Kamitani, T., Chmura, K., Chan, E. D.
(2003). Role of the NF-{kappa}B Signaling Pathway and {kappa}B cis-Regulatory Elements on the IRF-1 and iNOS Promoter Regions in Mycobacterial Lipoarabinomannan Induction of Nitric Oxide. Infect. Immun.
71: 1442-1452
[Abstract]
[Full Text]
-
Trajkovic, V., Singh, G., Singh, B., Singh, S., Sharma, P.
(2002). Effect of Mycobacterium tuberculosis-Specific 10-Kilodalton Antigen on Macrophage Release of Tumor Necrosis Factor Alpha and Nitric Oxide. Infect. Immun.
70: 6558-6566
[Abstract]
[Full Text]
-
Roig, E. A., Richer, E., Canonne-Hergaux, F., Gros, P., Cellier, M. F. M.
(2002). Regulation of NRAMP1 gene expression by 1{alpha},25-dihydroxy-vitamin D3 in HL-60 phagocytes. J. Leukoc. Biol.
71: 890-904
[Abstract]
[Full Text]
-
van Crevel, R., Ottenhoff, T. H. M., van der Meer, J. W. M.
(2002). Innate Immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev.
15: 294-309
[Abstract]
[Full Text]
-
Hacking, D., Rockett, K., Hull, J., Kwiatkowski, D.
(2002). Synergistic action of cytokines and purified respiratory syncytial virus in nitric oxide induction. J. Leukoc. Biol.
71: 729-730
[Full Text]
-
Waters, W. R., Nonnecke, B. J., Rahner, T. E., Palmer, M. V., Whipple, D. L., Horst, R. L.
(2001). Modulation of Mycobacterium bovis-Specific Responses of Bovine Peripheral Blood Mononuclear Cells by 1,25-Dihydroxyvitamin D3. CVI
8: 1204-1212
[Abstract]
[Full Text]
-
Chan, E. D., Chan, J., Schluger, N. W.
(2001). What is the Role of Nitric Oxide in Murine and Human Host Defense against Tuberculosis? . Current Knowledge. Am. J. Respir. Cell Mol. Bio.
25: 606-612
[Abstract]
[Full Text]
-
Hutley, L. J., Herington, A. C., Shurety, W., Cheung, C., Vesey, D. A., Cameron, D. P., Prins, J. B.
(2001). Human adipose tissue endothelial cells promote preadipocyte proliferation. Am. J. Physiol. Endocrinol. Metab.
281: E1037-E1044
[Abstract]
[Full Text]
-
Hori, M., Kita, M., Torihashi, S., Miyamoto, S., Won, K.-J., Sato, K., Ozaki, H., Karaki, H.
(2001). Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. Am. J. Physiol. Gastrointest. Liver Physiol.
280: G930-G938
[Abstract]
[Full Text]
-
Chan, E. D., Morris, K. R., Belisle, J. T., Hill, P., Remigio, L. K., Brennan, P. J., Riches, D. W. H.
(2001). Induction of Inducible Nitric Oxide Synthase-NO{middle dot} by Lipoarabinomannan of Mycobacterium tuberculosis Is Mediated by MEK1-ERK, MKK7-JNK, and NF-{kappa}B Signaling Pathways. Infect. Immun.
69: 2001-2010
[Abstract]
[Full Text]
-
Rook, G.A.W., Seah, G., Ustianowski, A.
(2001). M. tuberculosis: immunology and vaccination. Eur Respir J
17: 537-557
[Abstract]
[Full Text]
-
Kusner, D. J., Adams, J.
(2000). ATP-Induced Killing of Virulent Mycobacterium tuberculosis Within Human Macrophages Requires Phospholipase D. J. Immunol.
164: 379-388
[Abstract]
[Full Text]